274 related articles for article (PubMed ID: 34565331)
1. Expression and clinical implications of basic leucine zipper ATF-like transcription factor 2 in breast cancer.
Lin Y; Zhou X; Peng W; Wu J; Wu X; Chen Y; Cui Z
BMC Cancer; 2021 Sep; 21(1):1062. PubMed ID: 34565331
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and Prognostic Potential of Circulating and Tissue BATF2 in Nasopharyngeal Carcinoma.
Cui Z; Lin Y; Hu D; Wu J; Peng W; Chen Y
Front Mol Biosci; 2021; 8():724373. PubMed ID: 34778372
[No Abstract] [Full Text] [Related]
3. m
Xie JW; Huang XB; Chen QY; Ma YB; Zhao YJ; Liu LC; Wang JB; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Zheng CH; Huang CM; Li P
Mol Cancer; 2020 Jul; 19(1):114. PubMed ID: 32650804
[TBL] [Abstract][Full Text] [Related]
4. Exosomal miR-361-3p promotes the viability of breast cancer cells by targeting ETV7 and BATF2 to upregulate the PAI-1/ERK pathway.
Li Y; Fan L; Yan A; Ren X; Zhao Y; Hua B
J Transl Med; 2024 Jan; 22(1):112. PubMed ID: 38282047
[TBL] [Abstract][Full Text] [Related]
5. The tumor-suppressive role of BATF2 in esophageal squamous cell carcinoma.
Han T; Wang Z; Yang Y; Shu T; Li W; Liu D; Li P; Qi R; Ren Y; Li L; Liu H; Zhang S; Zhang L
Oncol Rep; 2015 Sep; 34(3):1353-60. PubMed ID: 26135942
[TBL] [Abstract][Full Text] [Related]
6. [The expression and clinical significance of BATF2 in oral tongue squamous cell carcinoma].
Wen H; Tang J; Liu B; Sun C
Zhonghua Kou Qiang Yi Xue Za Zhi; 2015 Jan; 50(1):13-7. PubMed ID: 25779069
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic value of the cancer-testis antigen lactate dehydrogenase C4 in breast cancer.
Cui Z; Chen Y; Hu M; Lin Y; Zhang S; Kong L; Chen Y
Clin Chim Acta; 2020 Apr; 503():203-209. PubMed ID: 31794764
[TBL] [Abstract][Full Text] [Related]
8. Androgen Receptor mRNA levels determine the prognosis in triple-negative breast cancer patients.
Govindan S; Siraganahalli Eswaraiah M; Basavaraj C; Adinarayan M; Sankaran S; Bakre M
BMC Cancer; 2020 Aug; 20(1):745. PubMed ID: 32778063
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression of BATF2 is significantly associated with poor prognosis in oral tongue squamous cell carcinoma.
Wen H; Chen Y; Hu Z; Mo Q; Tang J; Sun C
Oncol Rep; 2014 Jan; 31(1):169-74. PubMed ID: 24252932
[TBL] [Abstract][Full Text] [Related]
10. BATF2 reverses multidrug resistance of human gastric cancer cells by suppressing Wnt/β-catenin signaling.
Yang W; Wu B; Ma N; Wang Y; Guo J; Zhu J; Zhao S
In Vitro Cell Dev Biol Anim; 2019 Jun; 55(6):445-452. PubMed ID: 31140101
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of BATF2 is associated with a poor prognosis in hepatocellular carcinoma.
Ma H; Liang X; Chen Y; Pan K; Sun J; Wang H; Wang Q; Li Y; Zhao J; Li J; Chen M; Xia J
Int J Cancer; 2011 Feb; 128(4):771-7. PubMed ID: 20473897
[TBL] [Abstract][Full Text] [Related]
12. BATF2 balances the T cell-mediated immune response of CADM with an anti-MDA5 autoantibody.
Li C; Liu M; Liu K; Li M; Liu Y; Li T; Wei Y; Long Y; He W; Shi X; Li Y; Zhang H
Biochem Biophys Res Commun; 2021 Apr; 551():155-160. PubMed ID: 33740622
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical co-expression status of cytokeratin 5/6, androgen receptor, and p53 as prognostic factors of adjuvant chemotherapy for triple negative breast cancer.
Maeda T; Nakanishi Y; Hirotani Y; Fuchinoue F; Enomoto K; Sakurai K; Amano S; Nemoto N
Med Mol Morphol; 2016 Mar; 49(1):11-21. PubMed ID: 26009308
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of serum exosomal SUMO1P3 predicts unfavorable prognosis in triple negative breast cancer.
Na-Er A; Xu YY; Liu YH; Gan YJ
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):154-160. PubMed ID: 33506903
[TBL] [Abstract][Full Text] [Related]
15. BATF2 inhibits chemotherapy resistance by suppressing AP-1 in vincristine-resistant gastric cancer cells.
Yang W; Zhao S; Wu B; Xu J; Wu Z; Guo J; Zeng R
Cancer Chemother Pharmacol; 2019 Dec; 84(6):1279-1288. PubMed ID: 31549215
[TBL] [Abstract][Full Text] [Related]
16. Carboxypeptidase A4 negatively correlates with p53 expression and regulates the stemness of breast cancer cells.
Wang Y; Xie Y; Niu Y; Song P; Liu Y; Burnett J; Yang Z; Sun D; Ran Y; Li Y; Sun L
Int J Med Sci; 2021; 18(8):1753-1759. PubMed ID: 33746592
[No Abstract] [Full Text] [Related]
17. High methionyl-tRNA synthetase expression predicts poor prognosis in patients with breast cancer.
Jin Q; Liu G; Wang B; Li S; Ni K; Wang C; Ren J; Zhang S; Dai Y
J Clin Pathol; 2020 Dec; 73(12):803-812. PubMed ID: 32404475
[TBL] [Abstract][Full Text] [Related]
18. Targeting Batf2 for infectious diseases and cancer.
Guler R; Roy S; Suzuki H; Brombacher F
Oncotarget; 2015 Sep; 6(29):26575-82. PubMed ID: 26376615
[TBL] [Abstract][Full Text] [Related]
19. Comparisons of p53, KI67 and BRCA1 expressions in patients with different molecular subtypes of breast cancer and their relationships with pathology and prognosis.
Li Y; Zhang X; Qiu J; Pang T; Huang L; Zeng Q
J BUON; 2019; 24(6):2361-2368. PubMed ID: 31983107
[TBL] [Abstract][Full Text] [Related]
20. BATF2 Deficiency Promotes Progression in Human Colorectal Cancer via Activation of HGF/MET Signaling: A Potential Rationale for Combining MET Inhibitors with IFNs.
Liu Z; Wei P; Yang Y; Cui W; Cao B; Tan C; Yu B; Bi R; Xia K; Chen W; Wang Y; Zhang Y; Du X; Zhou X
Clin Cancer Res; 2015 Apr; 21(7):1752-63. PubMed ID: 25762344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
